Category: News

AUSTIN, Texas − February 20, 2017 − Asuragen, Inc., a global molecular diagnostics company, announced today that it has entered into
Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing.
Search

Recent

[archives type="yearly"/]